The Department of Defense (DoD) is offering the Neurofibromatosis Investigator-Initiated Research Award to decrease the clinical impact of Neurofibromatosis (NF). This grant aims to support innovative, high-impact research, foster new directions, encourage multidisciplinary collaborations, and develop the next generation of NF investigators. It promotes translational and clinical studies to move promising ideas from bench to bedside, building a balanced portfolio across NF1, NF2, and schwannomatosis. Key areas of emphasis include cognitive and social dysfunction, drug discovery, tumor heterogeneity using genomics/epigenetics, post-adolescent manifestations, novel disease markers like imaging/proteomics, and pain management in NF. The research should provide insight into NF development, lead to substantial improvements in diagnosis/treatment, and enhance the quality of life for persons with NF. Applicants must include relevant preliminary or published data.
Opportunity ID: 233115
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | W81XWH-13-NFRP-IIRA |
Funding Opportunity Title: | DoD Neurofibromatosis Investigator Initiated Research Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 4 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | May 03, 2013 |
Last Updated Date: | – |
Original Closing Date for Applications: | Jul 11, 2013 |
Current Closing Date for Applications: | Jul 11, 2013 |
Archive Date: | Aug 10, 2013 |
Estimated Total Program Funding: | $3,680,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: | The vision of the FY13 NFRP is to decrease the clinical impact of NF. Toward this end, the NFRP seeks to: support innovative, high-impact research that will foster new directions for and address neglected issues in NF research; sponsor multidisciplinary and multi-institutional collaborations that will bring new perspectives to the field; foster the next generation of NF investigators; promote translational and clinical studies to move promising ideas from bench to bedside; develop a balanced portfolio of meritorious research related to all aspects of NF1, NF2, and schwannomatosis. Areas of Emphasis: The FY13 NFRP strongly encourages research applications that specifically address the critical needs of the NF community in one or more of the following Areas of Emphasis: Cognitive and social dysfunction in the setting of NF; Drug discovery for the treatment of NF; Heterogeneity of neurofibromas and other NF-related tumors using genomics, epigenetics, systems biology, or other similar approaches; Manifestations of NF post-adolescence; Novel disease markers such as imaging and proteomics of NF; Pain in the setting of NF. The NFRP Investigator-Initiated Research Award supports innovative basic and clinically oriented research that will: Provide insight into the development of NF, or into particular lesions or abnormalities that occur as a result of NF; Result in substantial improvements over todays approach to the diagnosis and treatment of NF; and Have an impact on the quality of life of persons with NF. Applications must include preliminary or published data that is relevant to NF and the proposed research project. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
301-682-5507 Email:help@cdmrp.org mil |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 233115 Full Announcement-1 -> nfrp_fy13 iira pa_gg.pdf
Packages
Agency Contact Information: | CDMRP Help Desk 301-682-5507 Email: help@cdmrp.org mil |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
12.420 | PKG00176413 | May 03, 2013 | Jul 11, 2013 | View |
Package 1
Mandatory forms
233115 RR_SF424_1_2-1.2.pdf
233115 PerformanceSite_1_4-1.4.pdf
233115 RR_Budget-1.1.pdf
233115 RR_KeyPersonExpanded_1_2-1.2.pdf
Optional forms
233115 RR_SubawardBudget30-1.2.pdf